drugset / Trial / NCT07743138
STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)
RandomizedSingle-groupOpen-labelTreatment
Summary
To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ACC or PPGL.
Timeline
- Start
- 2027-02-07
- Primary completion
- 2028-05-01
- Completion
- 2030-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivonescimab | Monoclonal antibody | — | Intravenous |